CompBrief BY VELARION

Companies Pediatrix Medical Group, Inc.

Pediatrix Medical (MD): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Pediatrix Medical Group, Inc.’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$14,140,217CEO Mark Ordan · source
Say-on-pay support97.28%Latest vote · source
CEO vs. named peers99th pct.Of 14 peer CEOs
CEO pay ratio91:1To the median employee · source

CEO pay, last three years

  • $14,140,217FY2025

CEO total pay was $14,140,217 in fiscal 2025; the brief holds no earlier figure for this CEO.

FY2025: salary $970,014 · bonus $2,000,000 · stock awards $8,456,024 · option awards $0

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Pediatrix Medical Group, Inc. in fiscal 2025?
As disclosed, Mark Ordan (Chief Executive Officer) was the highest-paid executive at Pediatrix Medical Group, Inc. in fiscal 2025, with total compensation of $14,140,217.
How does Pediatrix Medical Group, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Mark Ordan's total compensation ranked at the 99th percentile of Pediatrix Medical Group, Inc.'s disclosed peer group.
What is Pediatrix Medical Group, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Pediatrix Medical Group, Inc.'s CEO-to-median employee pay ratio was 91:1.
How did shareholders vote on Pediatrix Medical Group, Inc.'s executive compensation?
As disclosed, 97.28% of shareholders supported Pediatrix Medical Group, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Pediatrix Medical Group, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Pediatrix Medical Group, Inc. reported total board compensation of $2,123,945 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Mark Ordan$970,014$2,000,000$8,456,024$0$2,700,000$0$14,179$14,140,217
Chief Executive Officer
Don Neeb229,1671,000,0003,569,2430518,73301255,317,268
Executive Vice President, Chief Investment & Strategy Officer
Mary Ann Moore500,00001,391,93601,125,000014,2163,031,152
Executive Vice President, General Counsel, Chief Administrative Officer and Secretary
James Swift54,1670730,720068,98101,922,0132,775,881
Former Chief Executive Officer
Kasandra Rossi437,5000598,2760810,000014,2611,860,037
Executive Vice President, Chief Financial Officer and Treasurer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Mark Ordan$14,140,217———
Don Neeb5,317,268———
Mary Ann Moore3,031,1522,388,5921,834,988↑ +642,560
James Swift2,775,8813,301,0122,237,839↓ −525,131
Kasandra Rossi1,860,0371,344,756—↑ +515,281

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The Company designs its executive compensation program to attract and retain the best executive workforce in the healthcare services industry while aligning executive interests with shareholder value creation. A substantial portion of compensation is performance-based, tied to rigorous financial and strategic objectives, with a focus on long-term value creation through disciplined capital allocation and operating performance.

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantSemler Brossy Consulting Group
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Don NeebPSU2025-08-01027,116—54,232$324,850
Don NeebRSU2025-08-01——81,346—974,525
Don NeebPSU2025-08-010320,000—320,0002,269,868
Mark OrdanPSU2025-06-01064,783—129,566916,679
Mark OrdanRSU2025-06-01——194,347—2,750,010
Mark OrdanPSU2025-01-120640,000—640,0004,789,335
Kasandra RossiPSU2025-06-0106,945—13,89098,272
James SwiftPSU2025-06-01035,055—70,110496,028
Mary Ann MoorePSU2025-06-01022,800—45,600322,620
Mary Ann MoorePSU2025-06-01011,779—23,558166,673
Mary Ann MooreRSU2025-06-01——53,004—750,007
Kasandra RossiRSU2025-06-01——26,502—375,003
Kasandra RossiPSU2025-06-0108,834—17,668125,001
James SwiftPSU2025-03-20016,586—33,172234,692
Mary Ann MoorePSU2025-03-20010,787—21,574152,636

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Don Neeb$974,525$2,594,718$072.7%
Mark Ordan2,750,0105,706,014067.5%
Kasandra Rossi375,003223,273037.3%
James Swift0730,7200100.0%
Mary Ann Moore750,007641,929046.1%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Kasandra RossiPSU6,945—$148,554
Kasandra RossiRSU7,929—169,601
Kasandra RossiRSU8,334—178,264
Kasandra RossiPSU8,834—188,959
Mary Ann MoorePSU10,787—230,734
Mary Ann MoorePSU10,788—230,755
Mary Ann MoorePSU11,779—251,953
James SwiftPSU16,586—354,775
Kasandra RossiRSU17,955—384,057
Mary Ann MoorePSU22,800—487,692
Kasandra RossiRSU26,502—566,878
Mary Ann MooreRSU27,832—595,326
James SwiftPSU35,055—749,826
Mary Ann MooreRSU51,300—1,097,307
Mary Ann MooreRSU53,004—1,133,756
Kasandra RossiRSU1,298,801—27,781,353
Mary Ann MooreRSU2,826,389—60,456,424
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Guy P. SansoneIndependent · Lead Independent Director · Audit · Compensation and Talent · Nominating and Corporate Governance · Strategy (Chair)$146,667$165,006———$311,673
Thomas A. McEachinIndependent · Audit (Chair) · Nominating and Corporate Governance · Strategy117,500165,006———282,506
Shirley A. WeisIndependent · Compensation and Talent (Chair) · Nominating and Corporate Governance · Strategy108,333165,006———273,339
Michael A. RuckerIndependent · Audit · Nominating and Corporate Governance (Chair)104,167165,006———269,173
Laura A. LinynskyIndependent · Audit · Compensation and Talent90,000165,006———255,006
Sylvia J. YoungIndependent · Audit · Compensation and Talent90,000165,006———255,006
John M. Starcher JrIndependent · Compensation and Talent · Strategy90,000165,006———255,006
Kurt D. Newman, M.DIndependent · Nominating and Corporate Governance · Partial-year service47,500140,602———188,102
Mark S. OrdanEmployee director · Board Chair34,1340———34,134

Board fee structure and ownership guideline

Annual cash retainer$95,000
Annual equity retainer$165,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)30,000 / 20,000 / 15,000
Stock ownership guidelineThe chart below shows the multiple of base salary ownership requirements and actual ownership levels as of December 31, 2018: Dr. Medel 6x base salary; Mr. Calabro 4x base salary...

Total cost of the board

ComponentFY2025
Cash retainers and fees$828,301
Equity awards (grant-date value)$1,295,644
All other compensation$0
Total cost of the board$2,123,945

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Pediatrix Medical as a peer

Companies that benchmark against MD

17 companies name MD as a compensation peer

The list of companies that name MD as a peer is temporarily unavailable — recheck shortly.

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

Peer reciprocity

Of the companies Pediatrix Medical Group, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Pediatrix Medical Group, Inc..

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Pediatrix Medical Group, Inc.2025Mark Ordan$970,014$8,456,024$0$2,700,000$14,140,217
2The Ensign Group, Inc.2025Barry Port549,2642,912,355010,317,24713,804,700
3Chemed Corporation2025Kevin McNamara1,858,7922,883,5535,036,0211,486,97612,904,720
4Acadia Healthcare Company, Inc.2025Peter Scott534,09110,336,83101,984,50012,855,422
5Addus HomeCare Corporation2025R. Dirk Allison1,076,9239,767,87001,320,00012,190,449
6RadNet, Inc.2025Howard Berger3,000,0008,999,9660012,087,934
7Surgery Partners, Inc.2025J. Eric Evans1,050,0005,000,000006,083,862
8Brookdale Senior Living, Inc.2025Nikolas Stengle229,3104,283,9680403,5715,307,655
9Aveanna Healthcare Holdings Inc.2025Jeffrey Shaner750,0002,603,99301,500,0004,864,165
10Healthcare Services Group, Inc.2025Theodore Wahl1,005,1082,475,457818,544330,8514,725,723
11National HealthCare Corporation2025Stephen Flatt577,000505,215300,4811,280,0002,685,370
12ModivCare Inc.2024L. Heath Sampson792,8851,685,011002,520,122
13Cross Country Healthcare, Inc.2025Kevin Clark18,2692,177,134002,355,403
14Premier, Inc.2023Gary Small617,077309,5900119,3401,107,726
—Amedisys, Inc.——————not in coverage universe

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Pediatrix Medical Group, Inc.180%RSU 50 · PSU 50NoSemler Brossy Consulting Group
Acadia Healthcare Company, Inc.not disclosedPSU 60 · RSU 40Yes — Relative TSR compared to the TSR peer groupFerguson Partners
Addus HomeCare Corporationnot disclosedRestricted Stock 100not disclosedFW Cook
Amedisys, Inc.not disclosednot disclosednot disclosednot disclosed
Aveanna Healthcare Holdings Inc.200%PSU 50 · RSU 50NoAon Human Capital Solutions (division of Aon plc)
Brookdale Senior Living, Inc.125.7%not disclosedNoF.W. Cook & Co., Inc.
Chemed Corporationnot disclosednot disclosedYes — 3-Year Relative Total Shareholder Return (TSR)Compensation Strategies, Inc.
Cross Country Healthcare, Inc.20%RSU 60 · PSU 40NoPearl Meyer
Healthcare Services Group, Inc.not disclosednot disclosedYes — relative Total Shareholder Return (TSR)not disclosed
ModivCare Inc.not disclosedPRSU 60 · RSU 40not disclosedMeridian Compensation Partners, LLC
National HealthCare Corporationnot disclosednot disclosednot disclosedfalse
Premier, Inc.not disclosedPSU 67 · RSU 33Yes — 3-year Total Shareholder Return (rTSR)Pearl Meyer & Partners, LLC
RadNet, Inc.not disclosedRSU 100NoPearl Meyer
Surgery Partners, Inc.not disclosedPSU 60 · Restricted Stock 40NoFrederic W. Cook & Co., Inc. (FW Cook)
The Ensign Group, Inc.not disclosednot disclosednot disclosedWillis Towers Watson

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-0770,257,8321,960,93115,56897.28%Passed
20252025-05-0867,114,5284,951,665333,45493.13%Passed
20242024-05-0971,662,7633,286,99835,88995.61%Passed
20232023-05-1173,569,3272,311,93527,96696.95%Passed
20222022-05-1234,566,40445,167,188191,31043.35%Failed
20212021-05-1262,368,26414,588,32823,36481.04%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-05-0797.28%a
20252025-05-0893.13%b
20242024-05-0995.61%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted as votes cast either in favor of or against the election of the nominees for Director, the ratification of the appointment of our independent auditors, the advisory vote on executive compensation or the approval of the Pediatrix Medical Group, Inc.”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted as votes cast either in favor of or against the election of the nominees for Director, the ratification of the appointment of our independent auditors or the advisory vote on executive compensation.”.

c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted as votes cast either in favor of or against the election of the nominees for Director, the ratification of the appointment of our independent auditors or the advisory vote on executive compensation.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)91 : 1
CEO total compensation$14,170,209
Median employee compensation$155,070
Insider trades since the proxy

No insider equity transactions reported since the proxy statement.

Sources (62 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Mark Ordan. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 55. As printed: 14,140,217. View filing ↗
  • Section 01, Don Neeb. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 55. As printed: 5,317,268. View filing ↗
  • Section 01, Mary Ann Moore. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 55. As printed: 3,031,152. View filing ↗
  • Section 01, James Swift. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 55. As printed: 2,775,881. View filing ↗
  • Section 01, Kasandra Rossi. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 55. As printed: 1,860,037. View filing ↗
  • Section 03, Don Neeb PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Don Neeb RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Don Neeb PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mark Ordan PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mark Ordan RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mark Ordan PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Kasandra Rossi PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, James Swift PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mary Ann Moore PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mary Ann Moore PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mary Ann Moore RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Kasandra Rossi RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Kasandra Rossi PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, James Swift PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Mary Ann Moore PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-03-27. Section “CEO Pay Ratio”. As printed: 91 : 1. View filing ↗
  • Section 08, Guy P. Sansone. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 311,673. View filing ↗
  • Section 08, Thomas A. McEachin. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 282,506. View filing ↗
  • Section 08, Shirley A. Weis. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 273,339. View filing ↗
  • Section 08, Michael A. Rucker. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 269,173. View filing ↗
  • Section 08, Laura A. Linynsky. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 255,006. View filing ↗
  • Section 08, Sylvia J. Young. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 255,006. View filing ↗
  • Section 08, John M. Starcher Jr. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 255,006. View filing ↗
  • Section 08, Kurt D. Newman, M.D. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 188,102. View filing ↗
  • Section 08, Mark S. Ordan. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 34,134. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-05-07. Item 5.07 · say-on-pay result. As reported: 97.28% (votes for as printed: 70,257,832). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-05-08. Item 5.07 · say-on-pay result. As reported: 93.13% (votes for as printed: 67,114,528). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-05-09. Item 5.07 · say-on-pay result. As reported: 95.61% (votes for as printed: 71,662,763). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 828,301 + equity 1,295,644 + all other 0 = 2,123,945, summed across the director compensation table rows.
  • Pediatrix Medical Group, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 14,140,217. View filing ↗
  • The Ensign Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in The Ensign Group, Inc.'s own proxy. As printed: 13,804,700. View filing ↗
  • Chemed Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. View filing ↗
  • Acadia Healthcare Company, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Acadia Healthcare Company, Inc.'s own proxy. As printed: 12,855,422. View filing ↗
  • Addus HomeCare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Addus HomeCare Corporation's own proxy. As printed: 12,190,449. View filing ↗
  • RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
  • Surgery Partners, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. View filing ↗
  • Brookdale Senior Living, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Brookdale Senior Living, Inc.'s own proxy. As printed: 5,307,655. View filing ↗
  • Aveanna Healthcare Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Aveanna Healthcare Holdings Inc.'s own proxy. As printed: 4,864,165. View filing ↗
  • Healthcare Services Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in Healthcare Services Group, Inc.'s own proxy. As printed: 4,725,723. View filing ↗
  • National HealthCare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in National HealthCare Corporation's own proxy. As printed: 2,685,370. View filing ↗
  • ModivCare Inc., Section 10b CEO total. DEF 14A, filed 2025-04-30. CEO total compensation as printed in ModivCare Inc.'s own proxy. As printed: 2,520,122. View filing ↗
  • Cross Country Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-30. CEO total compensation as printed in Cross Country Healthcare, Inc.'s own proxy. As printed: 2,355,403. View filing ↗
  • Premier, Inc., Section 10b CEO total. DEF 14A, filed 2024-03-18. CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 1,107,726. View filing ↗
  • Section 10a, Surgery Partners, Inc. reciprocity. DEF 14A. Surgery Partners, Inc. names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, The Ensign Group, Inc. reciprocity. DEF 14A. The Ensign Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Pediatrix Medical Group, Inc.. View filing ↗
  • Section 10a, Aveanna Healthcare Holdings Inc. reciprocity. DEF 14A. Aveanna Healthcare Holdings Inc. names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Premier, Inc. reciprocity. DEF 14A. Premier, Inc.'s most recent proxy was read; its disclosed peer group does not include Pediatrix Medical Group, Inc.. View filing ↗
  • Section 10a, Healthcare Services Group, Inc. reciprocity. DEF 14A. Healthcare Services Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Pediatrix Medical Group, Inc.. View filing ↗
  • Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc. names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Acadia Healthcare Company, Inc. reciprocity. DEF 14A. Acadia Healthcare Company, Inc.'s most recent proxy was read; its disclosed peer group does not include Pediatrix Medical Group, Inc.. View filing ↗
  • Section 10a, Addus HomeCare Corporation reciprocity. DEF 14A. Addus HomeCare Corporation names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, ModivCare Inc. reciprocity. DEF 14A. ModivCare Inc.'s most recent proxy was read; its disclosed peer group does not include Pediatrix Medical Group, Inc.. View filing ↗
  • Section 10a, Brookdale Senior Living, Inc. reciprocity. DEF 14A. Brookdale Senior Living, Inc. names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Chemed Corporation reciprocity. DEF 14A. Chemed Corporation names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Cross Country Healthcare, Inc. reciprocity. DEF 14A. Cross Country Healthcare, Inc. names Pediatrix Medical Group, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
Get the full report — $500